• S&P 500: 1,342.64
  • Change: -0.69%
$5.07 -0.13 (-2.50%)
2/10/2012 3:59 PM

Celldex Therapeutics, Inc. (NASDAQ:CLDX)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.

Current Price $5.07 Mkt Cap $223.83M
Open $5.13 P/E Ratio 0.00
Prev. Close $5.20 Div. (Yield) N/A (N/A)
Daily Range $4.94 - $5.17 Volume 405,645
52-Wk Range $2.05 - $5.66 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think CLDX will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

202 Outperform
14 Underperform
 

All-Star Players

36 Outperform
6 Underperform
 

Wall Street

5 Outperform
0 Underperform
 

Top CLDX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

KattyKayK (33.61)
Submitted October 06, 2010

Celldex Therapeutics, Inc. has strong science underlying it's drug candidates. The therapeutic use of a vaccine to 'teach' the immune system to control or remove the cancer cells is a unique niche that has few other candidate drugs. The clinical… More

Add Comment | Reply | Report this Post

chtrplyr (< 20)
Submitted June 06, 2008

It will be bought out at $5 when it runs out of money which is has none of now along with huge losses.

Add Comment | Reply | Report this Post
CLDX VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about CLDX.

Recs

0
Member Avatar IBDvalueinvestin (99.35) Submitted: 1/31/2012 12:06:16 PM : Outperform Start Price: $4.82 CLDX Score: +2.56

Celldex has potential to have a blockbuster breast cancer drug:

Results from a Phase II study for CDX-011 - breast cancer are due for release before the summer. The company also is conducting Phase III and Phase II trial for its Rindopepimut in the treatment of glioblastoma.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar solanZRaider (< 20) Submitted: 5/16/2011 12:43:10 PM : Outperform Start Price: $3.52 CLDX Score: +42.23

irishred1

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar biotechspec (< 20) Submitted: 4/21/2011 12:43:47 PM : Outperform Start Price: $3.92 CLDX Score: +28.92

expecting a pop whenever the Phase III trials start CDX 110, also high short interest, possible short squeeze.

Report this Post Add Comment | Reply | Permalink
View All 33 Pitches »

Leaderboard

Find the members with the highest scoring picks in CLDX.

Score Leader

Ph1sh55

Ph1sh55 (29.13) Score: +102.60

The Score Leader is the player with the highest score across all their picks in CLDX.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
Loerke 85.27 10/18/2011 Outperform 3M $2.46 +106.10% +11.84% +94.26 0 Comment
Daxtonwin 99.76 6/2/2009 Underperform 5Y $10.30 -50.78% +43.15% +93.93 0 Comment
hwyman64 84.97 1/23/2009 Underperform 3W $6.52 -22.24% +69.01% +91.25 0 Comment
KidLucifer 98.53 4/13/2009 Underperform NS $7.19 -29.49% +59.88% +89.36 0 Comment
montys3 87.52 1/2/2012 Outperform 5Y $2.62 +93.51% +6.62% +86.89 0 Comment
broman700 < 20 9/23/2011 Outperform 5Y $2.52 +101.19% +19.85% +81.34 0 Comment
pear4000 87.40 8/11/2011 Outperform 1Y $2.67 +89.88% +14.64% +75.24 0 Comment
stemcells2011 < 20 8/22/2011 Outperform NS $2.66 +90.60% +16.66% +73.94 0 Comment
chtrplyr < 20 6/6/2008 Underperform 5Y $17.35 -70.78% +1.65% +72.43 1 Comment
Sliketa 69.65 12/12/2011 Outperform 5Y $2.85 +77.89% +7.53% +70.36 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackBreanMurray 65.65 11/2/2011 Outperform NS $3.00 +69.00% +8.45% +60.55 0 Comment
TrackOppenheimer 79.13 5/17/2011 Outperform NS $3.91 +29.67% +1.26% +28.41 0 Comment
TrackWedbush 84.95 10/1/2010 Outperform NS $4.09 +23.96% +16.85% +7.12 0 Comment
trackwbbsecuriti 38.22 5/5/2010 Outperform NS $7.92 -35.98% +15.27% -51.26 0 Comment
TrackRothCapital < 20 2/25/2010 Outperform NS $4.96 -19.15% +23.95% -43.10 5/3/2011 @ $4.01 0 Comment
TrackNeedham 92.52 4/17/2008 Outperform NS $12.37 -58.12% -34.99% -23.13 12/19/2008 @ $5.18 0 Comment
TrackEveillard 96.04 9/30/2007 Outperform NS $6.72 -24.55% -7.74% -16.82 1 Comment

Featured Broker Partners